Literature DB >> 23085257

Design considerations for supervised consumption facilities (SCFs): preferences for facilities where people can inject and smoke drugs.

Tara Marie Watson1, Carol Strike, Gillian Kolla, Rebecca Penn, Jennifer Jairam, Shaun Hopkins, Janine Luce, Naushaba Degani, Peggy Millson, Ahmed M Bayoumi.   

Abstract

BACKGROUND: Supervised consumption facilities (SCFs) aim to improve the health and well-being of people who use drugs by offering safer and more hygienic alternatives to the risk environments where people typically use drugs in the community. People who smoke crack cocaine may be willing to use supervised smoking facilities (SSFs), but their facility design preferences and the views of other stakeholders have not been previously investigated in detail.
METHODS: We consulted with people who use drugs and other stakeholders including police, fire and ambulance service personnel, other city employees and city officials, healthcare providers, residents, and business owners (N = 236) in two Canadian cities without SCFs and asked how facilities ought to be designed. All consultations were audio-recorded and transcribed. Thematic analyses were used to describe the knowledge and opinions of stakeholders.
RESULTS: People who use drugs see SSFs as offering public health and safety benefits, while other stakeholders were more sceptical about the need for SSFs. People who use drugs provided insights into how a facility might be designed to accommodate supervised injection and supervised smoking. Their strongest preference would allow both methods of drug use within the same facility with some form of physical separation between the two based on different highs, comfort regarding exposure to different methods of drug administration, and concerns about behaviours often associated with smoking crack cocaine. Other stakeholders raised a number of SSF implementation challenges worthy of consideration.
CONCLUSION: Decision-makers in cities considering SCF or SSF implementation should consider the opinions and preferences of potential clients to ensure that facilities will attract, retain, and engage people who use drugs.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085257     DOI: 10.1016/j.drugpo.2012.09.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  11 in total

1.  Post-war prevention: Emerging frameworks to prevent drug use after the War on Drugs.

Authors:  Dan Werb
Journal:  Int J Drug Policy       Date:  2017-07-19

2.  Supervised inhalation is an important part of supervised consumption services.

Authors:  Stacey Bourque; Em M Pijl; Erin Mason; Jill Manning; Takara Motz
Journal:  Can J Public Health       Date:  2019-02-06

3.  Policy windows for drug consumption rooms in Finland.

Authors:  Ali Unlu; Tuukka Tammi; Pekka Hakkarainen
Journal:  Nordisk Alkohol Nark       Date:  2022-01-17

4.  Ambivalence about supervised injection facilities among community stakeholders.

Authors:  Carol Strike; Tara Marie Watson; Gillian Kolla; Rebecca Penn; Ahmed M Bayoumi
Journal:  Harm Reduct J       Date:  2015-08-21

5.  Risky and rushed public crack cocaine smoking: the potential for supervised inhalation facilities.

Authors:  Pauline Voon; Lianping Ti; Huiru Dong; M-J Milloy; Evan Wood; Thomas Kerr; Kanna Hayashi
Journal:  BMC Public Health       Date:  2016-06-07       Impact factor: 3.295

6.  Public opinions about supervised smoking facilities for crack cocaine and other stimulants.

Authors:  Carol Strike; Nooshin Khobzi Rotondi; Tara Marie Watson; Gillian Kolla; Ahmed M Bayoumi
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-02-09

7.  Education and equipment for people who smoke crack cocaine in Canada: progress and limits.

Authors:  Carol Strike; Tara Marie Watson
Journal:  Harm Reduct J       Date:  2017-05-12

8.  Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.

Authors:  Benjamin A Bouvier; Beth Elston; Scott E Hadland; Traci C Green; Brandon D L Marshall
Journal:  Harm Reduct J       Date:  2017-02-20

9.  'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America.

Authors:  Benedikt Fischer; Caroline O'Keefe-Markman; Angelica Min-Hye Lee; Dimitri Daldegan-Bueno
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-02-15

10.  Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a specialty HIV hospital in Toronto, Canada: perspectives of people living with HIV.

Authors:  Katherine Rudzinski; Jessica Xavier; Adrian Guta; Soo Chan Carusone; Kenneth King; J Craig Phillips; Sarah Switzer; Bill O'Leary; Rosalind Baltzer Turje; Scott Harrison; Karen de Prinse; Joanne Simons; Carol Strike
Journal:  BMC Public Health       Date:  2021-07-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.